LUNG

Pulmonx Corporation

Sağlık

COMPLIANT — All screening ratios are below the thresholds; the company is compliant with halal investment criteria.

$3

Price (1 Year)

Participation Finance Screening Ratios

Non-compliant debt / Total market cap %18.2 / %30

Non-compliant assets / Total market cap %0.3 / %30

Non-compliant revenue / Total income %1.5 / %5

Ratios are taken from an AAOIFI-based screening file; this does not constitute a religious ruling.

About the Company

Pulmonx Corporation, a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease. It offers Zephyr Endobronchial Valve; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation.

Website

Analysis (Turkish): LUNG Hissesi Caiz mi, Helal mi? Pulmonx Corporation Katılım Analizi